Cargando…
Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick
BACKGROUND: Although legislation permits New Brunswick pharmacy professionals to administer a wide range of immunizations, public funding for these services is currently limited to immunizations against influenza and COVID-19 and was recently extended to include pneumococcal immunization (Pneu23) in...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331360/ https://www.ncbi.nlm.nih.gov/pubmed/37435502 http://dx.doi.org/10.1177/17151635231176498 |
_version_ | 1785070240972931072 |
---|---|
author | Folkins, Chris Gorman-Asal, Madeleine Brewster, Clark Foster, Rebecca Gulliver, Adrienne Thomson, Emily Singh, Paramdeep Miah, Pablo Magalhaes, Sandra McDonald, J. Ted |
author_facet | Folkins, Chris Gorman-Asal, Madeleine Brewster, Clark Foster, Rebecca Gulliver, Adrienne Thomson, Emily Singh, Paramdeep Miah, Pablo Magalhaes, Sandra McDonald, J. Ted |
author_sort | Folkins, Chris |
collection | PubMed |
description | BACKGROUND: Although legislation permits New Brunswick pharmacy professionals to administer a wide range of immunizations, public funding for these services is currently limited to immunizations against influenza and COVID-19 and was recently extended to include pneumococcal immunization (Pneu23) in individuals aged 65 years or older. We used administrative data to project health and economic outcomes associated with the current Pneu23 program and with extension of public funding to include: 1) younger adults aged 19 years or older in the Pneu23 program, and 2) tetanus boosters (Td/Tdap). METHODS: Two model scenarios were compared: a Physician-Only model in which physicians remain the only practitioners to administer publicly funded Pneu23 and Td/Tdap, and a Blended model in which this service is also provided by pharmacy professionals. Immunization rates by practitioner type were projected based on physician billing data accessed via the New Brunswick Institute for Research, Data and Training in conjunction with trends observed with influenza immunization by pharmacists. These projections were used along with published data to estimate health and economic outcomes under each model. RESULTS: Public funding of Pneu23 (65+), Pneu23 (19+) and Td/Tdap (19+) administration by pharmacy professionals is projected to yield increased immunization rates and physician time savings compared with the Physician-Only model. Public funding of Pneu23 and Td/Tdap administration by pharmacy professionals in those aged ≥19 years would result in cost savings, owing primarily to productivity losses avoided in the working age population. DISCUSSION: Increased immunization rates, physician time savings and cost savings may be realized if public funding were extended to include administration of Pneu23 in younger adults and Td/Tdap, by pharmacy practitioners. |
format | Online Article Text |
id | pubmed-10331360 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SAGE Publications |
record_format | MEDLINE/PubMed |
spelling | pubmed-103313602023-07-11 Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick Folkins, Chris Gorman-Asal, Madeleine Brewster, Clark Foster, Rebecca Gulliver, Adrienne Thomson, Emily Singh, Paramdeep Miah, Pablo Magalhaes, Sandra McDonald, J. Ted Can Pharm J (Ott) Research and Clinical BACKGROUND: Although legislation permits New Brunswick pharmacy professionals to administer a wide range of immunizations, public funding for these services is currently limited to immunizations against influenza and COVID-19 and was recently extended to include pneumococcal immunization (Pneu23) in individuals aged 65 years or older. We used administrative data to project health and economic outcomes associated with the current Pneu23 program and with extension of public funding to include: 1) younger adults aged 19 years or older in the Pneu23 program, and 2) tetanus boosters (Td/Tdap). METHODS: Two model scenarios were compared: a Physician-Only model in which physicians remain the only practitioners to administer publicly funded Pneu23 and Td/Tdap, and a Blended model in which this service is also provided by pharmacy professionals. Immunization rates by practitioner type were projected based on physician billing data accessed via the New Brunswick Institute for Research, Data and Training in conjunction with trends observed with influenza immunization by pharmacists. These projections were used along with published data to estimate health and economic outcomes under each model. RESULTS: Public funding of Pneu23 (65+), Pneu23 (19+) and Td/Tdap (19+) administration by pharmacy professionals is projected to yield increased immunization rates and physician time savings compared with the Physician-Only model. Public funding of Pneu23 and Td/Tdap administration by pharmacy professionals in those aged ≥19 years would result in cost savings, owing primarily to productivity losses avoided in the working age population. DISCUSSION: Increased immunization rates, physician time savings and cost savings may be realized if public funding were extended to include administration of Pneu23 in younger adults and Td/Tdap, by pharmacy practitioners. SAGE Publications 2023-07-07 /pmc/articles/PMC10331360/ /pubmed/37435502 http://dx.doi.org/10.1177/17151635231176498 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage). |
spellingShingle | Research and Clinical Folkins, Chris Gorman-Asal, Madeleine Brewster, Clark Foster, Rebecca Gulliver, Adrienne Thomson, Emily Singh, Paramdeep Miah, Pablo Magalhaes, Sandra McDonald, J. Ted Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick |
title | Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick |
title_full | Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick |
title_fullStr | Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick |
title_full_unstemmed | Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick |
title_short | Projected health and economic outcomes of extending public funding of pharmacy services to include administration of Pneu23 and Td/Tdap immunizations by pharmacy practitioners in New Brunswick |
title_sort | projected health and economic outcomes of extending public funding of pharmacy services to include administration of pneu23 and td/tdap immunizations by pharmacy practitioners in new brunswick |
topic | Research and Clinical |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10331360/ https://www.ncbi.nlm.nih.gov/pubmed/37435502 http://dx.doi.org/10.1177/17151635231176498 |
work_keys_str_mv | AT folkinschris projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT gormanasalmadeleine projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT brewsterclark projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT fosterrebecca projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT gulliveradrienne projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT thomsonemily projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT singhparamdeep projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT miahpablo projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT magalhaessandra projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick AT mcdonaldjted projectedhealthandeconomicoutcomesofextendingpublicfundingofpharmacyservicestoincludeadministrationofpneu23andtdtdapimmunizationsbypharmacypractitionersinnewbrunswick |